Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1996
05/17/1996WO1996014340A1 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof
05/17/1996WO1996014339A1 Antibodies
05/17/1996WO1996014336A1 Novel oxyntomodulin
05/17/1996WO1996014335A1 Cartilage-derived morphogenetic proteins
05/17/1996WO1996014334A1 IDENTIFICATION OF THE p21WAF1-PCNA INTERACTION SITE AND THERAPEUTIC APPLICATIONS THEREOF
05/17/1996WO1996014333A1 Peptides for anti-allergy treatment
05/17/1996WO1996014331A1 Modified neuropeptide y receptors
05/17/1996WO1996014328A1 Tumor necrosis factor-gamma
05/17/1996WO1996014111A1 Golf club receptacle
05/17/1996WO1996014085A1 External preparation for skin protection
05/17/1996WO1996014084A1 A storage stable water solution for infusion containing a thrombin inhibitor
05/17/1996WO1996014083A1 Application of superoxide dismutase in liposomes
05/17/1996WO1996014082A1 Methods and kits using macrophage stimulating protein
05/17/1996WO1996014081A1 Use of erythropoietin in the treatment of rheumatoid arthritis
05/17/1996WO1996014080A1 Glycosaminoglycan/megakaryocyte growth factor composition and therapeutical use thereof
05/17/1996WO1996014079A1 Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them
05/17/1996WO1996014077A1 Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
05/17/1996WO1996014074A1 Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
05/17/1996WO1996010639A3 The taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma
05/17/1996WO1996010419A3 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
05/17/1996WO1996008270A3 Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds
05/17/1996WO1996007398A3 Sustained release of peptides from pharmaceutical compositions
05/17/1996WO1995033463A3 Synergistic antibiotic compositions containing a perphyrin and an antibiotic
05/17/1996CA2204645A1 Novel oxyntomodulin
05/17/1996CA2204618A1 Respiratory syncytial virus protein g expressed on bacterial membrane
05/17/1996CA2204511A1 Production of recombinant peptides as natural hydrophobic peptide analorues
05/17/1996CA2204429A1 Porcine striatal cells and their use in treatment of neurological deficits due to neurodegenerative disease
05/17/1996CA2204428A1 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
05/17/1996CA2204427A1 Porcine mesencephalic cells and their use in treatment of neurological deficits due to neurodegenerative diseases
05/17/1996CA2204380A1 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof
05/17/1996CA2204362A1 Recombinant alternaria alternata allergens
05/17/1996CA2204256A1 Peptides for anti-allergy treatment
05/17/1996CA2204246A1 Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in aspergillus
05/17/1996CA2203909A1 Identification of the p21waf1-pcna interaction site and therapeutic applications thereof
05/17/1996CA2203396A1 A storage stable water solution for infusion containing a thrombin inhibitor
05/17/1996CA2180454A1 External preparation for skin protection
05/16/1996CA2135813A1 Treatment of obesity
05/15/1996EP0711835A1 Selection and expression of heterologous proteins using a selection-amplification-system
05/15/1996EP0711833A2 Survival motor neuron (SMN) gene: a gene for spinal muscular atrophy
05/15/1996EP0711832A2 Human metabotropic glutamate receptor, m Glu R2
05/15/1996EP0711829A2 Recombinant alphavirus vectors
05/15/1996EP0711559A2 Use of phosphatidylserines for the manufacture of a medicament for improving cerebration
05/15/1996EP0711550A1 Cyclosporin-containing soft capsule compositions
05/15/1996EP0711355A1 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors
05/15/1996EP0711346A1 Agonists and antagonists of human interleukin-10
05/15/1996EP0711345A1 B7-2: ctl a4/cd 28 counter receptor
05/15/1996EP0711344A1 Modified alpha-lactalbumin
05/15/1996EP0711343A1 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression
05/15/1996EP0711310A1 Human antibodies against varicella-zoster virus
05/15/1996EP0711308A1 Cell adhesion protein complexes with copper
05/15/1996EP0711307A1 Peptides for neutralizing the toxicity of lipid a
05/15/1996EP0711306A1 Treatment of diabetes using phosphorylated insulin
05/15/1996EP0711305A1 Protegrins
05/15/1996EP0711304A1 Nickel-free hemoglobin and methods for producing such hemoglobin
05/15/1996EP0711303A1 Biotinylation of proteins
05/15/1996EP0711283A1 Tetrahydro-1h-benzazepinones and hexahydroazepinones as selective cholecystokinin-b receptor antagonists
05/15/1996EP0711176A1 Stabilised immunoglobulin preparations and method for preparing same
05/15/1996EP0711174A1 Programmed cell death genes and proteins
05/15/1996EP0711173A1 Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof
05/15/1996EP0711167A1 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict
05/15/1996EP0679153A4 Amino acids and peptides having modified terminals.
05/15/1996EP0615445B1 Pharmaceutically applicable nanosol and process for preparing the same
05/15/1996EP0563389B1 Pharmaceutical aerosol preparation and its use for treatment and prophylaxis of viral diseases
05/15/1996EP0482013B1 Nonglycosylated human interleukin-3 analog proteins
05/15/1996EP0462182B1 Matrix metalloproteinase peptides: role in diagnosis and therapy
05/15/1996EP0458894B1 Lipid excipient for nasal delivery and topical application
05/15/1996DE19509279C1 Dermatomyositis-spezifisches Autoantigen Dermatomyositis-specific autoantigen
05/15/1996CN1122602A Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
05/15/1996CN1122577A Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
05/15/1996CN1122575A Stable liquid compositions of gamma interferon
05/15/1996CN1122574A A process for separation of components from red blood cells
05/15/1996CN1122573A Oxygen-reduced aqueous solution of factor VIII
05/15/1996CN1122248A Insulin analog formulations
05/15/1996CA2162770A1 Expression plasmid, a fusion protein, a transfected eukaryotic cell line, a method of producing foreign proteins, a foreign protein preparation as well as a pharmaceutical composition
05/15/1996CA2162648A1 Excitatory amino acid receptor protein and related nucleic acid compounds
05/14/1996US5516940 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
05/14/1996US5516896 Biologically active B-chain homodimers
05/14/1996US5516895 Antibodies specific towards gp 48
05/14/1996US5516894 Dna codes and proteins for genetic engineering and diagnosis
05/14/1996US5516889 Synthetic thrombin receptor peptides
05/14/1996US5516887 Luteinizing hormone releasing hormone antagonist peptides
05/14/1996US5516808 Antibiotic gel
05/14/1996US5516784 Anti-HIV (AIDS) agents
05/14/1996US5516766 Proteins adsorbed on cyclodextrins, such as heparin binding growth factor, fibroblast growth factor for polyionic derivatives
05/14/1996US5516759 LHRH antagonists having lactam groups at the N-terminus
05/14/1996US5516757 Antifungal
05/14/1996US5516756 Microbiocides
05/14/1996US5516755 Antitumor and antibacterial peptide and methods of use
05/14/1996US5516754 Method for the selective dissolution of cancer cells using a composition derived from the photosynthetic system of plants and mammalian embryonic tissue
05/14/1996US5516685 Isolation and characterization of a novel protease from Streptomyces lividans
05/14/1996US5516682 Subtilin variant of enhanced stability and activity
05/14/1996US5516675 Separation of lactoperoxidase, secretory component and lactoferrin from milk or whey with a cation exchange resin
05/14/1996US5516673 Preactivation of cellulose, polyvinyl alcohol, or the like with pyridine, pyrrole, pyridazine or their derivatives; further reaction with proteins; wound healing agents
05/14/1996US5516659 Anticoagulant, thrombolytic
05/14/1996US5516658 DNA encoding cytokines that bind the cell surface receptor hek
05/14/1996US5516656 Production of a new hirudin analog and anticoagulant pharmaceutical composition containing the same
05/14/1996US5516653 Genetic engineering
05/14/1996US5516652 DNA encoding prostaglandin receptor IP
05/14/1996US5516643 Diagnosis
05/14/1996US5516642 Polypeptides derived from major histocompatibility complex Class I antigen
1 ... 2788 2789 2790 2791 2792 2793 2794 2795 2796 2797 2798 2799 2800 2801 2802 2803 2804 2805 2806 2807 2808 ... 3163